Does the Use of Asthma-Controller Medication in Accordance with Guidelines Reduce the Incidence of Acute Exacerbations and Healthcare Costs?
Background In asthma, consistent control of chronic airway inflammation is crucial, and the use of asthma-controller medication has been emphasized. Our purpose in this study is to compare the incidence of acute exacerbation and healthcare costs related to the use of asthma-controller medication. Me...
Main Authors: | Suh-Young Lee, Kyungjoo Kim, Yong Bum Park, Kwang Ha Yoo |
---|---|
Format: | Article |
Language: | English |
Published: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2022-01-01
|
Series: | Tuberculosis and Respiratory Diseases |
Subjects: | |
Online Access: | http://www.e-trd.org/upload/pdf/trd-2021-0087.pdf |
Similar Items
-
The costs of asthma disease on the healthcare system
by: Kerim Yesildag
Published: (2022-03-01) -
The cost of asthma control
by: Chotirmall, Sanjay Haresh
Published: (2017) -
Study of Cost-Consequences Analysis Between Salbutamol With Aminophyllin For Exacerbation Asthma
by: Amelia Lorensia
Published: (2020-06-01) -
Real-World Effectiveness of Mepolizumab in Patients with Severe Asthma: An Examination of Exacerbations and Costs
by: Llanos JP, et al.
Published: (2020-01-01) -
The Asthma Cost in Oman
by: Nasser H. Al-Busaidi, et al.
Published: (2013-05-01)